Attached files
| file | filename |
|---|---|
| EX-32.01 - EXHIBIT 32.01 - BioSig Technologies, Inc. | ex_233029.htm |
| EX-31.02 - EXHIBIT 31.02 - BioSig Technologies, Inc. | ex_233028.htm |
| EX-31.01 - EXHIBIT 31.01 - BioSig Technologies, Inc. | ex_233027.htm |
| EX-23.2 - EXHIBIT 23.2 - BioSig Technologies, Inc. | ex_233377.htm |
| EX-21.1 - EXHIBIT 21.1 - BioSig Technologies, Inc. | ex_233026.htm |
| EX-4.1 - EXHIBIT 4.1 - BioSig Technologies, Inc. | ex_233025.htm |
| 10-K - FORM 10-K - BioSig Technologies, Inc. | biosig20201231_10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Prospectus Supplement on Form S-3 (No. 333-230448) of BioSig Technologies, Inc. of our report dated March 13, 2020, relating to the consolidated financial statements for the year ended December 31, 2019, which appear in this Form 10-K.
/s/ Liggett & Webb, P.A.
New York, NY
March 15, 2021